vimarsana.com

Latest Breaking News On - Ionis pharmaceuticals company profile - Page 1 : vimarsana.com

Ionis Pharmaceuticals (NASDAQ:IONS) Reaches New 1-Year Low at $36.44

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Free Report) shares reached a new 52-week low during mid-day trading on Wednesday . The company traded as low as $36.44 and last traded at $36.44, with a volume of 220851 shares traded. The stock had previously closed at $37.64. Analyst Ratings Changes Several equities analysts have recently weighed […]

United-states
Piper-sandler
Joseph-baroldi
William-blair
Nasdaq
Hedge-funds-weigh-in-on-ionis-pharmaceuticals
News-ratings-for-ionis-pharmaceuticals-daily
Ionis-pharmaceuticals
Ionis-pharmaceuticals-stock-down
Mather-group
Sunbelt-securities-inc
Wells-fargo-company

First Turn Management LLC Invests $18.04 Million in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)

First Turn Management LLC Invests $18.04 Million in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Canada
United-states
Piper-sandler
Joseph-baroldi
William-blair
Quarter-for-ionis-pharmaceuticals
Needham-company
Securities-exchange-commission
Ionis-pharmaceuticals
Nasdaq
Ionis-pharmaceuticals-inc
Lisanti-capital-growth

Ionis Pharmaceuticals (NASDAQ:IONS) Price Target Cut to $82.00 by Analysts at Wells Fargo & Company

Ionis Pharmaceuticals (NASDAQ:IONS) Price Target Cut to $82.00 by Analysts at Wells Fargo & Company
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

Canada
United-states
Joseph-baroldi
Piper-sandler
William-blair
Ionis-pharmaceuticals-company-profile
Fifth-third-bancorp
Grandfield-dodd
Ionis-pharmaceuticals-inc
Institutional-trading-of-ionis-pharmaceuticals
Ionis-pharmaceuticals
Wells-fargo-company

Wells Fargo & Company Trims Ionis Pharmaceuticals (NASDAQ:IONS) Target Price to $82.00

Wells Fargo & Company Trims Ionis Pharmaceuticals (NASDAQ:IONS) Target Price to $82.00
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United-states
Piper-sandler
Joseph-baroldi
Needham-company
Wells-fargo-company
Ionis-pharmaceuticals
Ionis-pharmaceuticals-inc
Grandfield-dodd
Ionis-pharmaceuticals-company-profile
Fifth-third-bancorp
Ionis-pharmaceuticals-price-performance
Third-bancorp

Ionis Pharmaceuticals (NASDAQ:IONS) Earns Buy Rating from Needham & Company LLC

Ionis Pharmaceuticals (NASDAQ:IONS) Earns Buy Rating from Needham & Company LLC
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United-states
Joseph-baroldi
Piper-sandler
Lisanti-capital-growth
Charles-schwab-investment-management-inc
Ionis-pharmaceuticals-inc
Securities-exchange-commission
Analyst-recommendations-for-ionis-pharmaceuticals
Jpmorgan-chase-co
Needham-company
Ionis-pharmaceuticals
Ionis-pharmaceuticals-company-profile
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.